文献速递泌尿生殖腹部CT

延胡索酸水合酶缺陷型肾细胞癌与乳头状II型肾细胞癌的多层螺旋CT特征对比

Multidetector CT Characteristics of Fumarate Hydratase-Deficient Renal Cell Carcinoma and Papillary Type II Renal Cell Carcinoma.
PubMed 文献 · Korean J Radiol · 2021-09-24

回顾性纳入24例病理证实的FH缺陷型RCC(15例胚系突变、9例体细胞突变)和54例乳头状II型RCC,比较两组MDCT特征。FH缺陷型RCC患者更年轻、肿瘤更大,囊实性模式更常见(20/24 vs 16/54),淋巴结和远处转移更频繁;增强各期强化程度均显著高于乳头状II型RCC。胚系与体细胞突变亚组间各参数无显著差异。

要点

  • 年轻患者肾脏囊实性肿块,尤其伴偏心实性成分时,应警惕FH缺陷型RCC。
  • FH缺陷型RCC较乳头状II型RCC更大、更易淋巴结和远处转移。
  • FH缺陷型RCC皮质髓质期和肾实质期强化程度显著高于乳头状II型RCC。

关键影像表现/征象

  • 所有病灶均为单侧单发。
  • FH缺陷型RCC中囊实性模式更常见(20/24 vs 16/54,p<0.001),其中16例(80.0%)囊实性肿瘤表现为典型多囊伴薄而光滑的壁和/或分隔,并可见偏心实性成分。
  • FH缺陷型RCC淋巴结转移(16/24 vs 16/54,p=0.003)和远处转移(11/24 vs 3/54,p<0.001)更频繁。
  • 两组平扫期衰减相似;FH缺陷型RCC皮质髓质期(76.3%±25.0% vs 60.2±23.6,p=0.008)和肾实质期(87.7±20.5 vs 71.2±23.9,p=0.004)衰减更高。

诊断标准与关键数值

  • FH缺陷型RCC较乳头状II型RCC更年轻(40.4±14.7 vs 58.6±12.6岁,p<0.001)、更大(8.1±4.1 vs 5.4±3.2 cm,p=0.002)。
  • 皮质髓质期绝对强化(39.0±24.8 vs 27.1±22.7,p=0.001)和肾实质期绝对强化(50.5±20.5 vs 38.2±21.9,p=0.001)在FH缺陷型RCC更高。
  • 相对肾皮质强化比在皮质髓质期(0.35±0.26 vs 0.24±0.19,p=0.001)和肾实质期(0.43±0.24 vs 0.29±0.19,p<0.001)在FH缺陷型RCC更高。
  • 胚系与体细胞突变亚组间所有参数均无显著差异。

临床应用与阅片要点

  • 年轻患者发现肾脏囊实性肿块,尤其呈多囊伴薄光滑壁/分隔及偏心实性成分时,应将FH缺陷型RCC纳入鉴别诊断。
  • 注意评估淋巴结和远处转移,FH缺陷型RCC转移倾向高于乳头状II型RCC。
  • 增强扫描皮质髓质期和肾实质期强化程度较高有助于区分FH缺陷型RCC与乳头状II型RCC。

局限性

  • 回顾性研究设计。
  • 样本量较小(FH缺陷型RCC仅24例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the multidetector computed tomography (MDCT) features of fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) with germline or somatic mutations, and compare them with those of papillary type II RCC (pRCC type II).

MATERIALS AND METHODS: A total of 24 patients (mean ± standard deviation, 40.4 ± 14.7 years) with pathologically confirmed FH-deficient RCC (15 with germline and 9 with somatic mutations) and 54 patients (58.6 ± 12.6 years) with pRCC type II were enrolled. The MDCT features were retrospectively reviewed and compared between the two entities and mutation subgroups, and were correlated with the clinicopathological findings.

RESULTS: All the lesions were unilateral and single. Compared with pRCC type II, FH-deficient RCC was more prevalent among younger patients (40.4 ± 14.7 vs. 58.6 ± 12.6, p < 0.001) and tended to be larger (8.1 ± 4.1 vs. 5.4 ± 3.2, p = 0.002). Cystic solid patterns were more common in FH-deficient RCC (20/24 vs. 16/54, p < 0.001), with 16 of the 20 (80.0%) cystic solid tumors having showed typical polycystic and thin smooth walls and/or septa, with an eccentric solid component. Lymph node (16/24 vs. 16/54, p = 0.003) and distant (11/24 vs. 3/54, p < 0.001) metastases were more frequent in FH-deficient RCC. FH-deficient RCC and pRCC type II showed similar attenuation in the unenhanced phase. The attenuation in the corticomedullary phase (CMP) (76.3% ± 25.0% vs. 60.2 ± 23.6, p = 0.008) and nephrographic phase (NP) (87.7 ± 20.5, vs. 71.2 ± 23.9, p = 0.004), absolute enhancement in CMP (39.0 ± 24.8 vs. 27.1 ± 22.7, p = 0.001) and NP (50.5 ± 20.5 vs. 38.2 ± 21.9, p = 0.001), and relative enhancement ratio to the renal cortex in CMP (0.35 ± 0.26 vs. 0.24 ± 0.19, p = 0.001) and NP (0.43 ± 0.24 vs. 0.29 ± 0.19, p < 0.001) were significantly higher in FH-deficient RCC. No significant difference was found between the FH germline and somatic mutation subgroups in any of the parameters.

CONCLUSION: The MDCT features of FH-deficient RCC were different from those of pRCC type II, whereas there was no statistical difference between the germline and somatic mutation subgroups. A kidney mass with a cystic solid pattern and metastatic tendency, especially in young patients, should be considered for FH-deficient RCC.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Yang L, Li XM, Hu YJ, et al. Multidetector CT Characteristics of Fumarate Hydratase-Deficient Renal Cell Carcinoma and Papillary Type II Renal Cell Carcinoma. Korean J Radiol. 2021. PMID: 34668351. doi:10.3348/kjr.2021.0212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。